People · Operator
Named in public records as an officer, director or promoter · active 2010–2013 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioconnect Systems Inc | — | Biotechnology | Series A | $11.0M | $327.9M | 2012 |
| Acorn Cardiovascular Inc | — | Other Technology | Pre-Seed | $478K | $20.3M | 2010 |
Robert G. Weisskoff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert G. Weisskoff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles G. Hadley | 2 | 4 |
| Steven Anderson | 1 | 6 |
| Mark G Mitchnick | 1 | 1 |
| Buzz G Benson | 1 | 1 |
| Kevin R Bassett | 1 | 1 |
| Sigrid G Van Bladel | 1 | 1 |
| Ralph R Zickert | 1 | 1 |
| Michael D. Dugery | 1 | 1 |
| Paul R Lundsford, Jr. | 1 | 1 |
| Adam D. Dakin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.